Your browser doesn't support javascript.
loading
Transfusion of D positive red cells to selected D-negative patients. / Transfusión de hematíes D positivo a pacientes seleccionados D negativo.
Zalba Marcos, Saoia; Antelo Caamaño, María Luisa; Galbete Jiménez, Arkaitz; Rodriguez Wilhelmi, Pablo; Aranguren Azparren, Alicia; García Erce, José Antonio.
Afiliação
  • Zalba Marcos S; Servicio de Hematología y Hemoterapia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
  • Antelo Caamaño ML; Servicio de Hematología y Hemoterapia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
  • Galbete Jiménez A; Unidad de Metodología, Fundación Miguel Servet, NAVARRABIOMED-Centro de Investigación Biomédica, Unidad de Metodología, Pamplona, Navarra, España.
  • Rodriguez Wilhelmi P; Servicio de Hematología y Hemoterapia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
  • Aranguren Azparren A; Servicio de Hematología y Hemoterapia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
  • García Erce JA; Banco de Sangre y Tejidos de Navarra, Servicio Navarro de Salud, Osasunbidea, Pamplona, Navarra, España; Grupo de Trabajo de la Sociedad Española de Transfusión Sanguínea «Hemoterapia basada en sentido común¼; Grupo Español de Rehabilitación Multimodal (GERM), Instituto Aragonés de Ciencias de la Sa
Med Clin (Barc) ; 154(11): 425-432, 2020 06 12.
Article em En, Es | MEDLINE | ID: mdl-31791806
BACKGROUND: To transfuse packed red blood cells isogroup ABO D is a usual transfusion practice. However, when there is not enough D negative blood available, we can transfuse positive red blood cells to negative patients. Immunocompetent D negative individuals may develop serologically detectable anti-D antibodies within 3 months after exposure to D positive red blood cells. MATERIAL AND METHOD: Over the last 18 years, we have experienced situations of D negative blood cell scarcity. In these situations, we have applied a clinical assistance protocol, selecting patients with lower risk of alloimmunization and chronic transfusion requirements. We have retrospectively evaluated this policy for the use of D positive red blood cells in D negative patients, focussing on alloinmunization and mortality. RESULTS: Applying the protocol, 3% of D negative patients were transfused with D positive units, with an alloimmunization rate of 12.3%. The rate of alloimmunization was higher in the younger age group and in those transfused with more units. No haemolytic reactions were reported. Mortality in the alloimmunized group was lower. CONCLUSION: The use of D positive red blood cells in selected D negative patients does not induce adverse reactions, is a safe practice and allows saving of a product that is sometimes limited.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Isoanticorpos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Isoanticorpos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article